Literature DB >> 14614538

[Co-expression of CFA/I and CS6 of Enterotoxigenic Escherichia coli ( ETEC ) in Shigella flexneri 2a T32 Derivative Strain FWL01].

Ji-Ping Zheng1, Ling-Chun Wang, Peng Wang, Gang Luo, Shu-Qin Li, Hai-Qing Duan, Cui-Fen Huang, Zhao-Shan Zhang.   

Abstract

Among the known colonization factors of enterotoxigenic Escherichia coli (ETEC), CFA/I and CS6 (the common antigen in the CFA/IV fimbrial antigens ) are two of the most prevalent fimbriae found in clinical isolates but are never expressed by the same wild-type strains. In this study, CFA/I and CS6 of ETEC were co-expressed in Shigella flexneri 2a T32 derivative strain FWL01 by using a host-plasmid lethal balancing system based on asd gene. The results indicate that the recombinant plasmid carrying CFA/I and CS6 could be stably integrated in FWL01. Expression of the two antigens did not interfere the host growth. The results of immunofluorescence analysis showed that CFA/I and CS6 were localized on the surface of the strain FWL01. In Balb/c mice orally immunized with the recombinant strain, the immune responses against CFA/I and CS6 were observed. Those observations show the feasibility of a multivalent vaccine expressing different fimbrial antigens in attenuated Shigella flexneri.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614538

Source DB:  PubMed          Journal:  Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)        ISSN: 0582-9879


  2 in total

1.  Construction of a novel Shigella live-vector strain co-expressing CS3 and LTB/STm of enterotoxigenic E.coli.

Authors:  Ji-Ping Zheng; Zhao-Shan Zhang; Shu-Qin Li; Xiang-Xin Liu; Sheng-Ling Yuan; Peng Wang; De-Wen Zhan; Ling-Chun Wang; Cui-Fen Huang
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

2.  Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608(pCFAI) and SC608(pCFAI/LTB) that express antigens from enterotoxigenic Escherichia coli.

Authors:  Ryan T Ranallo; C Piyumi Fonseka; Fred Cassels; Jay Srinivasan; Malabi M Venkatesan
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.